GGrantIndex
← Leaderboards

Alexander Rotenberg

Boston Children'S Hospital

$6,547,133
Attributed
$8,143,067
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,143,067 · 9

By mechanism

R01$4,111,837 · 2
R21$1,962,785 · 4
K08$866,700 · 1
R61$701,745 · 1
R41$500,000 · 1

Top collaborators

Most similar at Boston Children'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainProtocols DocumentationLeadPathologicEpilepsySeizuresPhysiologic PulseTranscranial Magnetic StimulationFutureResponseInterneuronsBaseElectroencephalographyAnimalsFunctional DisorderAnimal ModelSymptomsPreventDown-RegulationRattusNeuronsAntiepileptogenicIn VivoEpileptogenesis

Grant awards (24)

Developing Brain Penetrable AAV Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$500,000
R41 · FY2025 · NS · contact PI
Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$349,044
R61 · FY2025 · NS · contact PI
Mitigating Post-Traumatic Epileptogenesis by Enhancing Synaptic Glutamate Transport via Long-Term Non-Bactericidal Beta-Lactam Administration$265,500
R21 · FY2025 · NS · contact PI
Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$352,701
R61 · FY2024 · NS · contact PI
Mitigating Post-Traumatic Epileptogenesis by Enhancing Synaptic Glutamate Transport via Long-Term Non-Bactericidal Beta-Lactam Administration$221,250
R21 · FY2024 · NS · contact PI
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$265,500
R21 · FY2023 · NS · contact PI
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$221,250
R21 · FY2022 · NS · contact PI
Astrocytic Glutamate Transporter 1 (GLT-1) enhancement for the treatment of seizures in Dravet Syndrome$486,750
R21 · FY2021 · NS · contact PI
Neurophysiologic investigation of somatosensory dysfunction in Autism Spectrum Disorders$502,535
R21 · FY2020 · MH · contact PI
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis$387,188
R01 · FY2019 · NS · contact PI
Cortical Plasticity in Autism Spectrum Disorders$437,682
R01 · FY2018 · MH · contact PI
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis$387,188
R01 · FY2018 · NS · contact PI
Cortical Plasticity in Autism Spectrum Disorders$437,670
R01 · FY2017 · MH
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis$387,188
R01 · FY2017 · NS · contact PI
Cortical Plasticity in Autism Spectrum Disorders$437,648
R01 · FY2016 · MH
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis$387,188
R01 · FY2016 · NS · contact PI
Cortical Plasticity in Autism Spectrum Disorders$437,188
R01 · FY2015 · MH
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis$369,195
R01 · FY2015 · NS · contact PI
Cortical Plasticity in Autism Spectrum Disorders$443,702
R01 · FY2014 · MH
Antiepileptogenesis by Transcranial Magnetic Stimulation$173,340
K08 · FY2011 · NS · contact PI
Antiepileptogenesis by Transcranial Magnetic Stimulation$173,340
K08 · FY2010 · NS · contact PI
Antiepileptogenesis by Transcranial Magnetic Stimulation$173,340
K08 · FY2009 · NS · contact PI
Antiepileptogenesis by Transcranial Magnetic Stimulation$173,340
K08 · FY2008 · NS · contact PI
Antiepileptogenesis by Transcranial Magnetic Stimulation$173,340
K08 · FY2007 · NS · contact PI